Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Inverse variance weighted,5,0.4 [0.26-0.6],1.57440887939488e-05,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MSLN,Mesothelin,Inverse variance weighted,25,0.77 [0.67-0.89],0.00028534957105954,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.51 [0.35-0.75],0.000528737037424937,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.63 [1.18-2.25],0.00315052242174507,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RTBDN,Retbindin,Inverse variance weighted,3,0.51 [0.32-0.82],0.00558049928658129,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.19 [1.05-1.35],0.00683653872911707,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.16 [1.04-1.3],0.00903635826917816,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD27,CD27 antigen,Inverse variance weighted,9,0.72 [0.56-0.93],0.0103476654822715,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,C7,Complement component C7,Inverse variance weighted,38,1.14 [1.03-1.27],0.0114147927353557,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FABP5,Fatty acid-binding protein 5,Wald ratio,1,0.46 [0.25-0.86],0.0140930975655102,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.53 [1.08-2.15],0.0152242835640838,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.73 [0.57-0.94],0.0155433138991985,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,21,1.27 [1.04-1.55],0.0169532695802907,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.63 [1.08-2.47],0.0212098549551712,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCN3,CCN family member 3,Inverse variance weighted,19,0.74 [0.56-0.96],0.0241104170673987,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.69 [0.5-0.96],0.0257940143553081,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.81 [0.67-0.98],0.0285103470928499,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,0.88 [0.78-0.99],0.0347849783717511,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.85 [0.73-0.99],0.0370846408073853,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,1.22 [1.01-1.47],0.038738976115115,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,0.63 [0.41-0.98],0.0391554834405278,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCG2,Secretogranin-2,Wald ratio,1,6.66 [1.07-41.38],0.0418010434905176,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,5,1.6 [1.01-2.54],0.0454334617878545,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,0.29 [0.08-0.99],0.0473365538651191,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD276,CD276 antigen,Inverse variance weighted,20,1.15 [1-1.33],0.0501755783433712,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.84 [0.7-1],0.0546163256168039,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,0.16 [0.02-1.04],0.0546856074768057,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.33 [0.99-1.78],0.0571344908159299,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,UMOD,Uromodulin,Inverse variance weighted,29,0.9 [0.81-1],0.0572994704498865,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.58 [0.33-1.02],0.0579541839372845,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.85 [0.72-1.01],0.0585522279015843,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLC,Galectin-10,Wald ratio,1,0.38 [0.14-1.04],0.0594962250839506,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,1.24 [0.99-1.56],0.0606624740123643,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.73 [0.53-1.01],0.061249030665319,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,0.14 [0.02-1.11],0.0627638059535882,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PENK,Proenkephalin-A,Inverse variance weighted,19,1.23 [0.99-1.53],0.065853816089345,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,0.86 [0.72-1.01],0.0705124836569161,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.71 [0.95-3.06],0.0719647109876026,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,15,0.82 [0.65-1.02],0.0721888040335891,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.1 [0.99-1.22],0.0732748469952749,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NFASC,Neurofascin,Inverse variance weighted,15,1.21 [0.98-1.49],0.0734565500522731,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRSS8,Prostasin,Inverse variance weighted,5,0.58 [0.31-1.06],0.0746373115199516,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EGFLAM,Pikachurin,Inverse variance weighted,19,1.14 [0.99-1.32],0.0757412889681076,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.63 [0.37-1.05],0.0773670503239837,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.28 [0.97-1.7],0.0803262278629134,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.83 [0.68-1.02],0.082731583278777,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.17 [0.98-1.39],0.0829463944308265,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EDN1,Endothelin-1,Inverse variance weighted,3,0.7 [0.47-1.05],0.0835798719750779,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RBP2,Retinol-binding protein 2,Wald ratio,1,3.48 [0.84-14.4],0.0855778209523563,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PSAP,Prosaposin,Inverse variance weighted,5,1.4 [0.95-2.05],0.0860839735009985,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTSS,Cathepsin S,Inverse variance weighted,23,1.16 [0.98-1.37],0.0902885071680443,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,1.64 [0.92-2.92],0.0914916345079601,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,0.9 [0.8-1.02],0.0915473005777155,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,0.61 [0.35-1.08],0.0920921751635371,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.3 [0.96-1.76],0.0926899033501902,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,17,1.22 [0.97-1.53],0.093783604804635,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.28 [0.96-1.72],0.0964719301936236,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CDH2,Cadherin-2,Inverse variance weighted,3,2.09 [0.87-5.06],0.100434131713842,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.31 [0.08-1.3],0.109489302299449,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.65 [0.39-1.1],0.111591108174261,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,0.91 [0.82-1.02],0.115070595430799,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.17 [0.02-1.56],0.116752007761618,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SWAP70,Switch-associated protein 70,Inverse variance weighted,5,0.62 [0.34-1.13],0.118273843516076,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.08 [0.98-1.19],0.119615554624053,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.11 [0.97-1.27],0.130187701487535,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,OSM,Oncostatin-M,Wald ratio,1,2.62 [0.75-9.13],0.130571302019812,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.78 [0.84-3.8],0.134501829253119,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.89 [0.77-1.04],0.13489339028126,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,1.37 [0.91-2.07],0.135096581839097,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.36 [0.09-1.39],0.136521377270961,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.49 [0.19-1.25],0.137130545152097,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LMNB2,Lamin-B2,Wald ratio,1,0.2 [0.02-1.68],0.137611997911772,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.31 [0.06-1.47],0.139357486482387,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,2,1.63 [0.85-3.12],0.141873258108387,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1.11 [0.97-1.27],0.142705107956067,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.66 [0.38-1.15],0.142933803347849,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.77 [0.54-1.09],0.145532228294023,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPON2,Spondin-2,Inverse variance weighted,4,0.74 [0.5-1.11],0.146250789783365,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,0.3 [0.06-1.54],0.148825847220204,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LCAT,Phosphatidylcholine-sterol acyltransferase,Wald ratio,1,1.79 [0.81-3.95],0.150362152495068,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTSL,Cathepsin L1,Wald ratio,1,0.26 [0.04-1.69],0.157989528952375,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.88 [0.74-1.05],0.15972273249609,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.26 [0.91-1.73],0.163423329295353,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SELENOP,Selenoprotein P,Inverse variance weighted,2,1.68 [0.81-3.5],0.163667878051453,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.87 [0.71-1.06],0.164105571680516,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PI3,Elafin,Inverse variance weighted,10,1.21 [0.93-1.58],0.164561895016433,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.92 [0.81-1.04],0.165967959990084,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.89 [0.76-1.05],0.166612077162818,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NPPC,C-type natriuretic peptide,Wald ratio,1,4.26 [0.54-33.64],0.169814013846502,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.38 [0.87-2.2],0.173517852170351,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.83 [0.64-1.09],0.176543748783852,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.65 [0.35-1.22],0.176790211267896,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KIF1C,Kinesin-like protein KIF1C,Wald ratio,1,0.18 [0.01-2.18],0.177406813223343,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL19,Interleukin-19,Inverse variance weighted,11,1.19 [0.92-1.55],0.178926366122528,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NT5E,5'-nucleotidase,Inverse variance weighted,45,1.09 [0.96-1.23],0.182385736448664,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.87 [0.7-1.07],0.182951635912465,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNC,Tenascin,Inverse variance weighted,12,0.78 [0.54-1.12],0.182955113354931,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,XCL1,Lymphotactin,Inverse variance weighted,31,0.91 [0.8-1.04],0.184138718818024,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,21,1.14 [0.94-1.39],0.184237430872141,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.86 [0.7-1.07],0.185185005522738,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,C9,Complement component C9,Inverse variance weighted,5,1.56 [0.81-3.02],0.185267488091422,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,0.85 [0.68-1.08],0.185638930042158,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.62 [0.79-3.33],0.18565179278908,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NTF3,Neurotrophin-3,Inverse variance weighted,8,0.78 [0.54-1.13],0.189078234595329,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,20,1.15 [0.93-1.41],0.190039348627327,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SEPTIN8,Septin-8,Inverse variance weighted,2,0.67 [0.36-1.22],0.190618784261334,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.84 [0.65-1.09],0.19234804862137,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,OCLN,Occludin,Inverse variance weighted,2,0.64 [0.33-1.25],0.192641377931976,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MILR1,Allergin-1,Inverse variance weighted,33,0.93 [0.83-1.04],0.195089634543871,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRG2,Bone marrow proteoglycan,Wald ratio,1,2.09 [0.68-6.39],0.196386933901579,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,1.88 [0.72-4.96],0.199327560505825,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GHR,Growth hormone receptor,Inverse variance weighted,38,1.07 [0.97-1.18],0.201850718299227,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.9 [0.76-1.06],0.206022009778789,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CALCA,Calcitonin,Inverse variance weighted,5,0.56 [0.23-1.38],0.20762856401335,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.46 [0.81-2.64],0.213563101385361,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,REN,Renin,Inverse variance weighted,4,0.78 [0.52-1.16],0.221025652442145,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.16 [0.91-1.47],0.2225388252521,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,S100P,Protein S100-P,Inverse variance weighted,2,0.48 [0.15-1.56],0.223424257862127,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MDK,Midkine,Inverse variance weighted,4,0.7 [0.4-1.24],0.223589829226024,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.16 [0.91-1.48],0.224525422274137,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,12,1.3 [0.85-1.98],0.225199672012216,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BAP18,Chromatin complexes subunit BAP18,Wald ratio,1,0.51 [0.17-1.52],0.228802204112602,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AGRN,Agrin,Inverse variance weighted,17,1.2 [0.89-1.61],0.229175278078646,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.26 [0.86-1.84],0.229511472978893,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CWC15,Spliceosome-associated protein CWC15 homolog,Wald ratio,1,0.38 [0.08-1.83],0.230162623210442,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.86 [0.68-1.1],0.235965955801762,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,3.31 [0.45-24.27],0.239619668163681,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.54 [0.75-3.16],0.24024064072983,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CST3,Cystatin-C,Inverse variance weighted,10,0.86 [0.66-1.11],0.241292214145734,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,0.92 [0.81-1.06],0.246118284437803,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AREG,Amphiregulin,Inverse variance weighted,3,0.57 [0.22-1.47],0.247546796937286,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLK4,Kallikrein-4,Inverse variance weighted,17,1.12 [0.92-1.36],0.248332260546739,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TCOF1,Treacle protein,Wald ratio,1,2.73 [0.49-15.2],0.250863136451255,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MMP7,Matrilysin,Inverse variance weighted,13,0.87 [0.7-1.1],0.253970141749475,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.08 [0.94-1.25],0.254922876674725,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,0.84 [0.61-1.14],0.255228732522035,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,0.87 [0.69-1.1],0.255948790561304,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LGALS3,Galectin-3,Inverse variance weighted,25,0.9 [0.75-1.08],0.257658161558927,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.55 [0.19-1.56],0.259019398278313,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.72 [0.41-1.27],0.259217641191033,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,1.45 [0.76-2.75],0.259249108535642,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.37 [0.79-2.35],0.260824238581593,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SDC4,Syndecan-4,Inverse variance weighted,8,1.25 [0.85-1.83],0.260883348759791,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.87 [0.69-1.11],0.260982875255709,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,1.7 [0.67-4.27],0.261114712124426,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.45 [0.75-2.8],0.264186349644945,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.59 [0.23-1.49],0.264454709999316,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.59 [0.23-1.5],0.265802350371718,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.44 [0.76-2.73],0.268174686631446,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,0.74 [0.43-1.27],0.269739334269505,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NRP1,Neuropilin-1,Inverse variance weighted,12,1.15 [0.9-1.47],0.271283224742031,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,0.93 [0.81-1.06],0.273430903843879,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PALM2,Paralemmin-2,Inverse variance weighted,8,1.21 [0.86-1.71],0.273536541184395,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,2,1.61 [0.68-3.81],0.274195929777424,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.11 [0.92-1.33],0.280335399112589,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.76 [0.46-1.25],0.28287263345897,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,0.74 [0.42-1.29],0.283019572394102,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.11 [0.92-1.35],0.283802716535066,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,0.65 [0.3-1.42],0.283901775020774,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.68 [0.33-1.38],0.283901775020775,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.64 [0.28-1.45],0.284501257551876,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ANG,Angiogenin,Inverse variance weighted,19,1.1 [0.92-1.32],0.285847038394673,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.87 [0.67-1.13],0.291147904166564,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.88 [0.69-1.12],0.296346353938995,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.17 [0.87-1.56],0.296991757186764,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ELN,Elastin,Inverse variance weighted,2,0.55 [0.18-1.7],0.297510468413117,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.91 [0.77-1.09],0.304314750838565,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.07 [0.94-1.21],0.305228590361376,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.92 [0.79-1.08],0.309639306826108,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.17 [0.87-1.58],0.309927233458629,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCN5,CCN family member 5,Inverse variance weighted,8,1.44 [0.71-2.94],0.310586511404671,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EPO,Erythropoietin,Inverse variance weighted,5,0.6 [0.22-1.62],0.3115665500872,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.87 [0.67-1.14],0.313634729989618,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BCAN,Brevican core protein,Inverse variance weighted,3,0.81 [0.54-1.22],0.316285635247935,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.93 [0.81-1.07],0.320731993890955,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NECTIN4,Nectin-4,Inverse variance weighted,7,1.14 [0.88-1.47],0.322487420615547,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,1.08 [0.93-1.24],0.325232340959836,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.09 [0.92-1.3],0.325885631087296,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.14 [0.88-1.46],0.32695897919189,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.05 [0.95-1.17],0.3271300197255,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.12 [0.9-1.39],0.328002663322838,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.65 [0.27-1.54],0.328246814351251,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PVR,Poliovirus receptor,Inverse variance weighted,27,0.94 [0.83-1.07],0.329731702158013,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.87 [0.67-1.15],0.334397686483037,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.18 [0.84-1.66],0.337939396512018,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.13 [0.88-1.45],0.338113851909455,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RSPO3,R-spondin-3,Inverse variance weighted,6,0.8 [0.51-1.26],0.339128673120886,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SLAMF8,SLAM family member 8,Inverse variance weighted,25,0.95 [0.84-1.06],0.340078543848987,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.09 [0.91-1.31],0.341004408268702,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ENAH,Protein enabled homolog,Inverse variance weighted,2,0.47 [0.1-2.24],0.34149277153017,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,OGN,Mimecan,Inverse variance weighted,30,1.09 [0.91-1.3],0.341942532865571,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,F7,Coagulation factor VII,Inverse variance weighted,21,1.1 [0.9-1.34],0.34420960108229,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.76 [0.42-1.35],0.344424142191313,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1.08 [0.92-1.26],0.348490762665134,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.35 [0.72-2.52],0.349932463747266,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.17 [0.84-1.64],0.352727465494354,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.31 [0.74-2.31],0.356441354982847,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,1.06 [0.94-1.19],0.357248207213336,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1.05 [0.95-1.16],0.361730041682885,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.91 [0.73-1.12],0.363492216777425,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,0.88 [0.66-1.16],0.367820826190028,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,0.83 [0.55-1.25],0.368197987070233,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.85 [0.6-1.21],0.373567228273651,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.09 [0.9-1.33],0.373897495630323,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.19 [0.81-1.76],0.374918386893743,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SRP14,Signal recognition particle 14 kDa protein,Wald ratio,1,0.48 [0.1-2.41],0.375568928676907,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,1.12 [0.87-1.43],0.377848564997803,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.12 [0.87-1.43],0.380744455123607,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.44 [0.07-2.79],0.381192794824821,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.63 [0.23-1.78],0.385785927328358,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HSPB6,Heat shock protein beta-6,Wald ratio,1,2.59 [0.3-22.33],0.386125777757706,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SELPLG,P-selectin glycoprotein ligand 1,Inverse variance weighted,6,1.06 [0.93-1.2],0.389838839011897,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.69 [0.29-1.62],0.393385708642245,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRSS2,Trypsin-2,Inverse variance weighted,3,1.27 [0.73-2.2],0.394892997268077,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.11 [0.87-1.41],0.397387890666551,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,0.78 [0.44-1.39],0.398250002188412,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.29 [0.72-2.32],0.398389674231578,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,0.82 [0.52-1.3],0.399404409955065,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.09 [0.89-1.34],0.400877655468393,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.76 [0.4-1.44],0.402034311550166,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GRN,Progranulin,Inverse variance weighted,7,1.12 [0.85-1.48],0.404703739928287,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.93 [0.78-1.11],0.405272925977683,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.9 [0.7-1.16],0.408700378673498,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC3B,Tetranectin,Inverse variance weighted,7,1.16 [0.81-1.66],0.408782601112442,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.52 [0.11-2.49],0.411230668366523,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.9 [0.71-1.15],0.414560968797891,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LGALS4,Galectin-4,Inverse variance weighted,4,0.8 [0.47-1.37],0.417945489468049,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.9 [0.7-1.16],0.418052022259948,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.87 [0.63-1.21],0.41944780079641,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MPO,Myeloperoxidase,Inverse variance weighted,11,1.09 [0.88-1.35],0.424174009181318,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.11 [0.85-1.46],0.430157711222566,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LGALS9,Galectin-9,Inverse variance weighted,26,1.08 [0.89-1.32],0.43081089959916,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,0.86 [0.59-1.26],0.436944671092134,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CHGB,Secretogranin-1,Inverse variance weighted,27,0.94 [0.82-1.09],0.437108204797514,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.06 [0.91-1.23],0.449650721526133,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.08 [0.88-1.33],0.450905510648307,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.08 [0.88-1.32],0.452195929731989,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.49 [0.07-3.18],0.452667067912422,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,1.07 [0.9-1.28],0.452893418818175,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.13 [0.82-1.54],0.454186521333847,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.76 [0.37-1.56],0.454196115121694,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.9 [0.67-1.2],0.455522865224878,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.79 [0.43-1.46],0.455656639259801,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,0.9 [0.69-1.18],0.457704531730087,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,17,0.88 [0.64-1.23],0.45867077686392,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.41 [0.57-3.53],0.458995633337043,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,1.27 [0.67-2.39],0.459634599443142,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.39 [0.03-4.69],0.459736498830039,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.27 [0.67-2.4],0.459790463451288,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.95 [0.82-1.09],0.460671966196081,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,0.94 [0.79-1.12],0.461430112105415,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.84 [0.52-1.34],0.461433087471668,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,0.81 [0.47-1.41],0.464383346591069,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.77 [0.39-1.55],0.465072602323444,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SERPINB8,Serpin B8,Inverse variance weighted,28,0.96 [0.85-1.08],0.466829931692471,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,3,0.86 [0.57-1.29],0.466865602242733,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,0.53 [0.09-3.01],0.47136610566698,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.56 [0.11-2.75],0.472389829468111,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.92 [0.72-1.16],0.476018418011581,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GUCA2A,Guanylin,Inverse variance weighted,9,1.15 [0.79-1.68],0.477319823546728,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MME,Neprilysin,Inverse variance weighted,3,1.45 [0.52-4.09],0.47887622087123,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,11,1.11 [0.83-1.49],0.479241783729269,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,1.12 [0.81-1.55],0.482177004157017,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.33 [0.6-2.93],0.482962606658421,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.06 [0.9-1.24],0.484167076333702,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AGRP,Agouti-related protein,Inverse variance weighted,3,0.73 [0.3-1.78],0.486469372763777,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,1.07 [0.88-1.31],0.486713860208763,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.08 [0.87-1.33],0.49089135262927,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,0.94 [0.77-1.13],0.492450263989674,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.92 [0.72-1.17],0.494285627124718,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,STC2,Stanniocalcin-2,Inverse variance weighted,3,0.72 [0.28-1.85],0.494575638174072,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,APCS,Serum amyloid P-component,Inverse variance weighted,4,0.89 [0.64-1.24],0.496190741289093,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.33 [0.59-2.98],0.496255972036078,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BSG,Basigin,Wald ratio,1,1.24 [0.67-2.32],0.496277418951154,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NRP2,Neuropilin-2,Inverse variance weighted,11,0.9 [0.66-1.22],0.497915700686627,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.11 [0.83-1.48],0.498469258131841,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.16 [0.75-1.79],0.4987966418123,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.68 [0.22-2.12],0.501562132833592,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.84 [0.49-1.42],0.508376892656125,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRTN3,Myeloblastin,Inverse variance weighted,21,0.94 [0.78-1.13],0.509353656047511,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,0.78 [0.37-1.64],0.509682854181596,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ITGB6,Integrin beta-6,Inverse variance weighted,11,1.08 [0.85-1.38],0.510551234919947,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL18,Interleukin-18,Inverse variance weighted,16,1.16 [0.74-1.83],0.513538294637964,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.18 [0.71-1.96],0.514144824704716,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.93 [0.74-1.16],0.514317941457259,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RSPO1,R-spondin-1,Inverse variance weighted,5,1.12 [0.79-1.6],0.5167650154864,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SDC1,Syndecan-1,Inverse variance weighted,2,0.82 [0.44-1.52],0.519472164843524,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,1.05 [0.9-1.23],0.522362104293295,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.18 [0.71-1.97],0.523993297430514,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GSR,"Glutathione reductase, mitochondrial",Wald ratio,1,1.1 [0.83-1.45],0.524302982937603,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.05 [0.9-1.22],0.526886991233426,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.88 [0.58-1.32],0.529059796860118,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.95 [0.81-1.12],0.529472726393265,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.11 [0.79-1.56],0.531114884203259,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL15,Interleukin-15,Wald ratio,1,0.07 [0-274.82],0.532197423732521,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.15 [0.74-1.8],0.532936585225046,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.92 [0.7-1.2],0.533517595256554,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,19,1.05 [0.9-1.22],0.547507486741651,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,1.14 [0.74-1.77],0.549690893937795,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,17,0.94 [0.76-1.15],0.549936856574521,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.88 [0.56-1.36],0.551265249657572,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.95 [0.81-1.12],0.556373750226831,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COLEC12,Collectin-12,Inverse variance weighted,11,0.9 [0.62-1.29],0.556751676531427,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CDH6,Cadherin-6,Inverse variance weighted,29,1.04 [0.91-1.2],0.559323303025355,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRTG,Protogenin,Inverse variance weighted,19,1.05 [0.9-1.22],0.562379946294847,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPON1,Spondin-1,Inverse variance weighted,21,0.94 [0.75-1.17],0.564334362202474,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,1.18 [0.66-2.11],0.570560154245635,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.12 [0.76-1.63],0.571351970049904,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.17 [0.67-2.05],0.571422628939609,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPP1,Osteopontin,Inverse variance weighted,8,0.84 [0.47-1.52],0.571465698938631,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,1.06 [0.86-1.32],0.575762857251421,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.59 [0.31-8.02],0.576032640662081,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,1.07 [0.85-1.33],0.578609838239646,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,0.94 [0.75-1.18],0.579834376043826,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,1.19 [0.64-2.19],0.580408321699068,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.38 [0.44-4.29],0.580444838436727,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.92 [0.7-1.23],0.582234277164057,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,0.94 [0.75-1.18],0.583766684037446,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PTN,Pleiotrophin,Inverse variance weighted,4,1.22 [0.59-2.52],0.584890766345136,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.04 [0.91-1.19],0.588453374014478,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1.05 [0.87-1.27],0.591702498834859,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.87 [0.52-1.45],0.592612132532948,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.08 [0.82-1.41],0.596325811878966,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TMSB10,Thymosin beta-10,Wald ratio,1,1.49 [0.34-6.53],0.597010932402877,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.06 [0.85-1.33],0.598585613588113,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.8 [0.35-1.82],0.600707565376644,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.93 [0.72-1.21],0.602394730333063,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.16 [0.67-2.01],0.605488105906123,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SETMAR,Histone-lysine N-methyltransferase SETMAR,Inverse variance weighted,6,1.09 [0.79-1.51],0.607845226252998,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MENT,Protein MENT,Inverse variance weighted,3,1.09 [0.78-1.54],0.609317121869551,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VWC2,Brorin,Inverse variance weighted,22,1.06 [0.85-1.33],0.609918862970982,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,8,0.93 [0.71-1.22],0.610138844737097,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.82 [0.39-1.76],0.616434198925206,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PALM,Paralemmin-1,Inverse variance weighted,6,1.12 [0.72-1.72],0.616689449853443,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLK10,Kallikrein-10,Inverse variance weighted,15,1.09 [0.79-1.5],0.617063311404543,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PKD2,Polycystin-2,Inverse variance weighted,3,1.29 [0.47-3.51],0.619635699031245,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.06 [0.85-1.31],0.620627352321922,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PGF,Placenta growth factor,Inverse variance weighted,2,1.75 [0.19-16.41],0.622896350989748,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.47 [0.32-6.83],0.623562610298124,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,S100A11,Protein S100-A11,Wald ratio,1,1.16 [0.64-2.11],0.624521837591744,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.07 [0.82-1.4],0.625053242672549,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTSO,Cathepsin O,Inverse variance weighted,6,0.91 [0.61-1.34],0.63071111481478,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.88 [0.52-1.48],0.631731276806014,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.82 [0.37-1.85],0.637154078257956,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.04 [0.87-1.25],0.638129735546483,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,0.95 [0.75-1.19],0.641068497154703,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.05 [0.85-1.3],0.643703422121268,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ROBO2,Roundabout homolog 2,Inverse variance weighted,2,0.67 [0.12-3.67],0.644230099310762,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.04 [0.89-1.21],0.645014623612345,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.04 [0.88-1.22],0.6470361095467,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.06 [0.83-1.35],0.654195162991413,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.25 [0.46-3.39],0.656427616886051,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,0.92 [0.65-1.31],0.656495606105258,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FBLN2,Fibulin-2,Inverse variance weighted,11,1.05 [0.84-1.32],0.657329785447504,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SERPIND1,Heparin cofactor 2,Wald ratio,1,0.78 [0.26-2.38],0.662748462203198,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,0.75 [0.21-2.73],0.664533304411279,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.96 [0.82-1.14],0.664563081611088,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD302,CD302 antigen,Inverse variance weighted,9,0.94 [0.7-1.26],0.670346185599461,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.07 [0.78-1.47],0.671194319126297,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.98 [0.89-1.08],0.678995379503415,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.08 [0.75-1.55],0.679230845964244,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TTR,Transthyretin,Inverse variance weighted,3,1.19 [0.52-2.76],0.680415745781647,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.81 [0.29-2.25],0.680590615914372,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AMBP,Protein AMBP,Inverse variance weighted,3,0.89 [0.5-1.57],0.68348196716839,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCN4,CCN family member 4,Inverse variance weighted,27,1.04 [0.87-1.24],0.686598242450138,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CHGA,Chromogranin-A,Inverse variance weighted,3,0.86 [0.42-1.76],0.687991978130618,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.03 [0.88-1.22],0.690247574997666,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,0.73 [0.16-3.39],0.692377560335377,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,1.08 [0.74-1.56],0.693928293069624,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CDH3,Cadherin-3,Inverse variance weighted,2,1.22 [0.45-3.33],0.696576226361268,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.1 [0.68-1.79],0.696850623620324,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.9 [0.53-1.54],0.697875281060827,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1.03 [0.9-1.17],0.70085809290277,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MB,Myoglobin,Wald ratio,1,1.56 [0.16-15.42],0.701585595085797,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.95 [0.72-1.25],0.702680050100621,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.96 [0.79-1.17],0.704187404266278,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.18 [0.5-2.81],0.704371573457785,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PKD1,Polycystin-1,Inverse variance weighted,12,0.94 [0.66-1.32],0.705273870711249,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL17C,Interleukin-17C,Inverse variance weighted,3,1.14 [0.59-2.2],0.706194418899852,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,0.87 [0.41-1.83],0.707229871500035,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,4,0.93 [0.62-1.38],0.708588798210161,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LGALS1,Galectin-1,Inverse variance weighted,6,1.05 [0.81-1.36],0.710778208708964,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NECTIN2,Nectin-2,Inverse variance weighted,5,1.05 [0.8-1.38],0.714479167418788,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BGLAP,Osteocalcin,Inverse variance weighted,2,0.8 [0.23-2.71],0.715011776890223,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.2 [0.46-3.13],0.715398147179384,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.95 [0.71-1.27],0.716981859560872,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.3 [0.32-5.3],0.71743150756689,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.09 [0.67-1.8],0.720449172961222,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.9 [0.52-1.58],0.720637678987723,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ALCAM,CD166 antigen,Inverse variance weighted,6,1.16 [0.52-2.57],0.720828441880765,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ITGA5,Integrin alpha-5,Wald ratio,1,1.3 [0.31-5.52],0.722032703897795,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,1.04 [0.83-1.3],0.722482436791953,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.93 [0.64-1.36],0.724615672116639,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.04 [0.82-1.33],0.729160388499151,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,24,1.03 [0.87-1.21],0.730110785935697,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.95 [0.7-1.28],0.730375951441186,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.88 [0.42-1.83],0.731933168600223,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLK14,Kallikrein-14,Inverse variance weighted,15,0.96 [0.74-1.23],0.732866791679023,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL24A1,Collagen alpha-1(XXIV) chain,Inverse variance weighted,5,0.95 [0.72-1.27],0.733321914856377,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.96 [0.75-1.23],0.733332656961195,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.93 [0.63-1.39],0.734335520813346,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Wald ratio,1,0.89 [0.46-1.73],0.735660040803256,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.98 [0.85-1.12],0.736511886102063,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.02 [0.89-1.18],0.73802378770812,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CNTN3,Contactin-3,Inverse variance weighted,14,1.04 [0.82-1.32],0.738138255058635,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.07 [0.72-1.6],0.73840090137513,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.26 [0.33-4.85],0.738637257679619,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,1.12 [0.56-2.25],0.739284808520784,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,0.98 [0.88-1.09],0.739554388758769,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,0.91 [0.5-1.63],0.740250191339188,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.09 [0.65-1.82],0.741120147535472,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.05 [0.8-1.38],0.741900438650615,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.03 [0.86-1.24],0.7446035317066,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.03 [0.85-1.24],0.747593098789452,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Inverse variance weighted,22,1.04 [0.8-1.36],0.752327843256952,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.91 [0.5-1.65],0.755927406627341,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLKB1,Plasma kallikrein,Inverse variance weighted,15,0.97 [0.81-1.16],0.75967098977809,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,0.95 [0.68-1.32],0.763434287306913,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.69 [0.06-8.07],0.768406379381526,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,1.03 [0.84-1.26],0.769594504378309,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.89 [0.4-1.98],0.76966081819891,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RETN,Resistin,Inverse variance weighted,9,1.03 [0.86-1.23],0.770242981694186,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.03 [0.82-1.3],0.770908662752427,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.08 [0.63-1.86],0.773334998144567,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NCAN,Neurocan core protein,Inverse variance weighted,3,0.88 [0.36-2.13],0.778007624561418,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,11,1.04 [0.79-1.37],0.779637526642168,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.89 [0.39-2.04],0.78157456630904,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.83 [0.23-3.01],0.781873860964637,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LMOD1,Leiomodin-1,Inverse variance weighted,5,1.13 [0.47-2.7],0.782587659530433,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,31,0.98 [0.88-1.1],0.784309582161905,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.9 [0.41-1.99],0.794826473544395,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.3 [0.18-9.47],0.795019255427251,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.05 [0.72-1.53],0.795146834796582,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,0.9 [0.4-2.02],0.795218383640294,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,1.04 [0.79-1.36],0.797076319935005,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.93 [0.55-1.59],0.79841688189963,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.03 [0.81-1.32],0.79991414240521,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.06 [0.68-1.64],0.80358261768462,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNN,Tenascin-N,Inverse variance weighted,44,0.99 [0.88-1.11],0.805679728552365,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,1.01 [0.92-1.11],0.807347418848261,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.97 [0.78-1.22],0.808594728785068,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.19 [0.29-4.91],0.808627397362814,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MATN2,Matrilin-2,Inverse variance weighted,18,0.97 [0.74-1.27],0.809655378194109,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.12 [0.43-2.91],0.813103417944814,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.96 [0.66-1.38],0.814020181080195,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.99 [0.89-1.1],0.814500227002432,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DSC2,Desmocollin-2,Inverse variance weighted,9,1.04 [0.76-1.42],0.821899786338161,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.03 [0.77-1.38],0.829755917139059,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD160,CD160 antigen,Inverse variance weighted,11,0.98 [0.79-1.21],0.8308379179754,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ENG,Endoglin,Inverse variance weighted,9,0.97 [0.72-1.3],0.837476370306677,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAYN,Layilin,Inverse variance weighted,20,0.97 [0.76-1.25],0.840752271095159,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLK11,Kallikrein-11,Inverse variance weighted,6,1.02 [0.85-1.22],0.844034912763162,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.88 [0.26-3.04],0.845605632838077,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.04 [0.71-1.52],0.846553522373558,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,1.14 [0.29-4.49],0.846603683692163,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.02 [0.85-1.21],0.849558272900488,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ITGA11,Integrin alpha-11,Inverse variance weighted,8,0.97 [0.73-1.3],0.851520161646759,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,1.03 [0.77-1.37],0.852440252795989,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.82 [0.11-6.28],0.852478142578038,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTSB,Cathepsin B,Inverse variance weighted,26,0.98 [0.83-1.17],0.852997844669896,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.01 [0.9-1.14],0.854499318062275,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.95 [0.56-1.62],0.855109546201889,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.95 [0.53-1.71],0.861586843158432,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LDLR,Low-density lipoprotein receptor,Wald ratio,1,1.36 [0.04-45.28],0.862110067434834,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.87-1.18],0.863209757595392,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.19 [0.16-8.69],0.86676029341985,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.02 [0.78-1.34],0.868202477893672,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.99 [0.84-1.16],0.868689336745273,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.01 [0.86-1.2],0.869257449440347,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,1.18 [0.15-9.32],0.87235040175065,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.01 [0.88-1.16],0.875748679133805,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MMP10,Stromelysin-2,Inverse variance weighted,22,1.02 [0.82-1.26],0.876028337968214,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.95 [0.53-1.71],0.876891218248117,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.94 [0.45-1.98],0.878077194760842,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VCAN,Versican core protein,Inverse variance weighted,31,1.01 [0.87-1.17],0.879114538436659,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,0.97 [0.7-1.36],0.879316665629011,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.16 [0.17-7.87],0.881238808529008,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,0.96 [0.6-1.54],0.881795674107111,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1.01 [0.89-1.15],0.882475327948146,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,1.01 [0.86-1.19],0.885572314054689,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.05 [0.55-2],0.885648520133098,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,0.99 [0.81-1.2],0.885934978891467,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.97 [0.67-1.42],0.886254085171108,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.91 [0.23-3.57],0.886912815488991,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLXDC2,Plexin domain-containing protein 2,Inverse variance weighted,6,0.96 [0.51-1.8],0.889148249435906,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,0.92 [0.28-3.04],0.892342398515554,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.96 [0.51-1.8],0.89460463668694,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC11A,C-type lectin domain family 11 member A,Inverse variance weighted,7,0.98 [0.77-1.26],0.897639863761475,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.07 [0.39-2.89],0.898057446389484,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.99 [0.8-1.22],0.898663691207081,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.07 [0.37-3.07],0.900936777416673,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,0.99 [0.87-1.13],0.903315055174814,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,4,1.04 [0.52-2.08],0.903694145490446,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,0.98 [0.71-1.35],0.907284926811094,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SNCG,Gamma-synuclein,Inverse variance weighted,36,1.01 [0.88-1.15],0.907748583327332,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.97 [0.57-1.65],0.90850019329167,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.96 [0.51-1.83],0.908633329994306,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SERPINA11,Serpin A11,Inverse variance weighted,31,0.99 [0.85-1.16],0.91046957967372,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.98 [0.63-1.52],0.911386119904937,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.98 [0.67-1.43],0.913201341947241,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.05 [0.47-2.32],0.913627554479609,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.02 [0.7-1.48],0.914958519992484,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.06 [0.38-2.97],0.915815168147828,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,0.97 [0.58-1.64],0.917295604417275,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PCDH17,Protocadherin-17,Inverse variance weighted,2,1.04 [0.51-2.1],0.917923606357496,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.12 [0.11-11.61],0.921611244207346,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.99 [0.74-1.31],0.923448828345978,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.01 [0.81-1.25],0.924356052015749,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PROC,Vitamin K-dependent protein C,Inverse variance weighted,4,0.95 [0.31-2.92],0.924626227356419,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD83,CD83 antigen,Inverse variance weighted,5,1.02 [0.61-1.71],0.925689674391323,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.01 [0.78-1.32],0.92628862482122,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,WIF1,Wnt inhibitory factor 1,Inverse variance weighted,2,0.97 [0.53-1.78],0.926584134979591,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,0.99 [0.85-1.16],0.928596917466389,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,6,0.97 [0.48-1.94],0.93063896219699,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CSTB,Cystatin-B,Inverse variance weighted,28,0.99 [0.84-1.18],0.93401095919314,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL8,Interleukin-8,Inverse variance weighted,6,0.96 [0.34-2.69],0.934171429627221,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GSN,Gelsolin,Inverse variance weighted,5,0.97 [0.49-1.94],0.934932874005853,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,1.04 [0.45-2.4],0.935504544324477,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.97 [0.45-2.09],0.937109136966272,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.01 [0.78-1.31],0.940176288199455,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.02 [0.61-1.71],0.943990696803334,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.98 [0.64-1.53],0.945679284130624,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1.02 [0.6-1.74],0.945810097826507,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CX3CL1,Fractalkine,Inverse variance weighted,9,0.99 [0.66-1.47],0.947597461716407,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Wald ratio,1,0.92 [0.08-10.32],0.948276162585291,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,0.98 [0.52-1.84],0.949226739409025,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1.01 [0.8-1.27],0.95136244526931,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1 [0.92-1.09],0.952984971793419,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.07 [0.1-10.99],0.954555890995108,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,1.02 [0.55-1.88],0.954780980619959,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.08 [0.08-14.96],0.954989051052815,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.03 [0.35-3.02],0.957544739077548,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.98 [0.54-1.8],0.957662620783599,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.03 [0.29-3.73],0.962083514707457,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DRAXIN,Draxin,Inverse variance weighted,13,0.99 [0.78-1.27],0.962909957552618,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.99 [0.78-1.26],0.962980336458575,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.99 [0.57-1.73],0.967508790887579,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,0.99 [0.73-1.36],0.968144238409043,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,0.99 [0.59-1.65],0.969887871568402,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,1 [0.79-1.27],0.973456328354817,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,F10,Coagulation factor X,Inverse variance weighted,9,1 [0.86-1.17],0.97591424127813,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,1 [0.77-1.29],0.978955030160656,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.99 [0.46-2.14],0.981436637064696,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.01 [0.57-1.77],0.982972954592886,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1 [0.74-1.36],0.983055083526086,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CFD,Complement factor D,Inverse variance weighted,11,1 [0.76-1.32],0.984915304552667,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1 [0.89-1.12],0.990953287338221,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1 [0.68-1.48],0.991050534039906,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,1.01 [0.11-9.34],0.99314262741722,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,1 [0.38-2.66],0.997752621994884,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1 [0.45-2.23],0.998917776142172,cis
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MENT,Protein MENT,Inverse variance weighted,28,0.74 [0.62-0.88],0.000692331822357558,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.5 [0.33-0.75],0.000791987530387912,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.2 [0.06-0.62],0.00553647139008991,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLXDC2,Plexin domain-containing protein 2,Inverse variance weighted,8,1.53 [1.09-2.14],0.0143391162838558,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,5.72 [1.41-23.21],0.0146711136423443,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCN3,CCN family member 3,Inverse variance weighted,17,0.73 [0.57-0.95],0.0168081909310627,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.73 [1.1-2.73],0.0177169834138,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.44 [0.22-0.87],0.0178243540128472,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.64 [0.44-0.93],0.018830910033613,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.08 [0.01-0.68],0.0205907524276046,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.63 [1.08-2.47],0.0212098549551712,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.55 [0.32-0.93],0.0260178751856708,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,2.25 [1.1-4.59],0.0264202720428488,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.66 [0.45-0.95],0.027193908738279,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.72 [1.06-2.79],0.0280785825203018,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PSAP,Prosaposin,Inverse variance weighted,13,1.36 [1.03-1.81],0.0300229894335632,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,1.31 [1.03-1.66],0.0300964180059706,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC11A,C-type lectin domain family 11 member A,Inverse variance weighted,14,0.63 [0.41-0.97],0.0352267457773078,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.38 [1.02-1.88],0.0354845350357563,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,0.31 [0.1-0.93],0.0357407263405701,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,48,1.16 [1.01-1.34],0.0375787980131006,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.55 [0.31-0.98],0.0416669725371677,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,2.46 [1.03-5.88],0.0434928367083516,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,17,1.67 [1.01-2.76],0.0436397379109518,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,1.37 [1.01-1.87],0.0443081005255058,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.9 [1-3.61],0.0506561585322946,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.74 [0.54-1],0.0516492516885635,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.56 [0.31-1.01],0.0522223722817108,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PENK,Proenkephalin-A,Inverse variance weighted,15,1.43 [1-2.06],0.0529986876893331,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SELENOP,Selenoprotein P,Inverse variance weighted,3,3.42 [0.97-12.12],0.0564922868050529,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BAP18,Chromatin complexes subunit BAP18,Wald ratio,1,0.16 [0.02-1.06],0.0578177571937865,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.65 [0.41-1.02],0.0589655607802795,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.97 [0.97-3.98],0.0599471255053075,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.86 [0.96-3.6],0.0639110563419666,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,2.47 [0.94-6.48],0.0653105553234477,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,2.94 [0.93-9.27],0.0661485343119285,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,2.8 [0.93-8.43],0.0661495492329036,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RETN,Resistin,Inverse variance weighted,19,1.45 [0.97-2.17],0.0664736134508154,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,1.71 [0.96-3.04],0.0698540332199112,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,3.94 [0.89-17.41],0.0701962955514198,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.31 [0.98-1.77],0.07054833487119,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.78 [0.94-3.35],0.0750375012285065,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD302,CD302 antigen,Inverse variance weighted,11,0.65 [0.4-1.05],0.0786789555086507,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,0.74 [0.53-1.04],0.0806089372122133,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.73 [0.93-3.22],0.0812129022323388,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,0.49 [0.22-1.09],0.0813728847318116,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.2 [0.03-1.22],0.0819179841366573,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.31 [0.08-1.19],0.0887915685334151,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,OCLN,Occludin,Inverse variance weighted,2,0.35 [0.1-1.18],0.0916065791618054,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KCTD5,BTB/POZ domain-containing protein KCTD5,Inverse variance weighted,5,0.47 [0.19-1.14],0.0957543237002489,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.6 [0.33-1.1],0.0958050654844721,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.49 [0.93-2.39],0.0965856477654121,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,POF1B,Protein POF1B,Inverse variance weighted,4,0.53 [0.25-1.13],0.099265276920617,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,WNT9A,Protein Wnt-9a,Wald ratio,1,0.13 [0.01-1.49],0.102010383913125,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.55 [0.26-1.13],0.1038676055305,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.2 [0.03-1.39],0.104516545387328,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.36 [0.94-1.98],0.105237296365428,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.4 [0.93-2.1],0.105967829125566,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.67 [0.41-1.09],0.10708057072922,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.69 [0.44-1.09],0.108417456735275,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPP1,Osteopontin,Inverse variance weighted,13,0.65 [0.39-1.1],0.108590878047725,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.68 [0.89-3.15],0.109065169604072,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.31 [0.08-1.3],0.109489302299449,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,1.32 [0.94-1.85],0.111266910367882,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MDK,Midkine,Inverse variance weighted,14,0.69 [0.44-1.09],0.112178481813681,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FAM3C,Protein FAM3C,Inverse variance weighted,3,2.87 [0.78-10.53],0.112227600265512,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.49 [0.2-1.18],0.112719805041082,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.86 [0.71-1.04],0.113644411519292,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GHR,Growth hormone receptor,Inverse variance weighted,26,0.76 [0.54-1.07],0.115480460677602,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.62 [0.34-1.13],0.115596272624593,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BRK1,Protein BRICK1,Inverse variance weighted,10,0.74 [0.51-1.08],0.116484610208844,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,0.38 [0.11-1.28],0.118684116697965,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.54 [0.89-2.66],0.121827782650861,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EGLN1,Egl nine homolog 1,Wald ratio,1,4.94 [0.65-37.43],0.122162112762577,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTSB,Cathepsin B,Inverse variance weighted,28,0.85 [0.69-1.04],0.123927727433668,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.75 [0.52-1.08],0.127339801919661,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.87 [0.83-4.22],0.13045478078549,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BCAN,Brevican core protein,Inverse variance weighted,12,0.65 [0.37-1.14],0.131164838273566,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.56 [0.26-1.19],0.133146302135631,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.7 [0.43-1.12],0.1343968766475,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,0.73 [0.49-1.1],0.136816199199009,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.44 [0.15-1.3],0.137103960913699,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.69 [0.85-3.38],0.137799034349299,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,0.65 [0.37-1.15],0.138248328050455,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.59 [0.86-2.94],0.138356564361304,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.2 [0.94-1.54],0.138519006084614,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1.17 [0.95-1.44],0.139256186745595,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,1.3 [0.92-1.85],0.142965376629682,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.45 [0.88-2.39],0.147981654883249,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MB,Myoglobin,Inverse variance weighted,9,1.51 [0.86-2.63],0.149837461592932,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.76 [0.81-3.82],0.149972681960069,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MSLN,Mesothelin,Inverse variance weighted,11,0.71 [0.44-1.14],0.151186149369292,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.9 [0.79-1.04],0.151284875618656,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.19 [0.94-1.51],0.152394210641566,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COLEC12,Collectin-12,Inverse variance weighted,3,2.39 [0.72-7.95],0.155406095667038,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD160,CD160 antigen,Inverse variance weighted,24,0.79 [0.57-1.09],0.156632084890848,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.24 [0.03-1.75],0.158612637412827,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,0.39 [0.11-1.45],0.160853139974502,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CDH2,Cadherin-2,Inverse variance weighted,21,1.26 [0.91-1.76],0.166823287592814,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,1.11 [0.96-1.29],0.172450538105512,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.73 [0.47-1.15],0.174045620616508,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,2.38 [0.68-8.37],0.176738252682281,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.37 [0.86-2.18],0.182409375556859,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,WIF1,Wnt inhibitory factor 1,Inverse variance weighted,31,1.19 [0.92-1.53],0.188042317132384,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLK10,Kallikrein-10,Wald ratio,1,4.49 [0.47-42.94],0.1919322878809,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.48 [0.82-2.69],0.19425516255544,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.17 [0.92-1.48],0.194833427751023,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,1.28 [0.88-1.86],0.197490477574021,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.66 [0.36-1.24],0.197559612747605,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,0.8 [0.57-1.13],0.200763727097533,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPON2,Spondin-2,Inverse variance weighted,3,0.47 [0.14-1.52],0.205349204292975,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,0.75 [0.49-1.17],0.207722894060804,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MILR1,Allergin-1,Inverse variance weighted,43,0.93 [0.84-1.04],0.210199370327603,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL15,Interleukin-15,Inverse variance weighted,35,0.85 [0.67-1.1],0.214021267059657,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CX3CL1,Fractalkine,Inverse variance weighted,12,1.44 [0.81-2.58],0.2152058293867,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.8 [0.56-1.14],0.215693827716493,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SETMAR,Histone-lysine N-methyltransferase SETMAR,Inverse variance weighted,2,3.12 [0.51-18.9],0.215851051135516,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.45 [0.12-1.62],0.219604020626595,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.85 [0.65-1.1],0.220949401717352,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.27 [0.87-1.86],0.221416701239868,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.37 [0.83-2.26],0.224309262724714,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.72 [0.42-1.23],0.229538996198989,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.72 [0.42-1.23],0.2296410837397,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.66 [0.33-1.31],0.231182622705938,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AGRP,Agouti-related protein,Inverse variance weighted,16,0.82 [0.59-1.14],0.231262282380495,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.41 [0.8-2.5],0.233706226364892,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SDC4,Syndecan-4,Inverse variance weighted,35,1.16 [0.91-1.47],0.234711423879354,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PI3,Elafin,Inverse variance weighted,18,1.17 [0.9-1.53],0.235235437845004,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MMP7,Matrilysin,Wald ratio,1,1.61 [0.73-3.54],0.235951169843424,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.49 [0.15-1.61],0.237751551522395,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,1.35 [0.82-2.21],0.239187890862023,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.1 [0.94-1.3],0.240096741832762,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LMNB2,Lamin-B2,Inverse variance weighted,8,1.58 [0.74-3.41],0.240722191820441,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,0.88 [0.7-1.09],0.243766666854467,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.74 [0.44-1.23],0.244114608192132,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.32 [0.05-2.18],0.244494827589811,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,0.31 [0.04-2.28],0.248546579083533,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.35 [0.81-2.24],0.249434781434331,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,S100A11,Protein S100-A11,Wald ratio,1,0.38 [0.07-1.98],0.249598315074141,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.24 [0.86-1.8],0.249769828159475,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.45 [0.77-2.74],0.253568968575249,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD83,CD83 antigen,Inverse variance weighted,14,1.29 [0.83-2],0.254239589865731,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.85 [0.64-5.32],0.254885712828238,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.45 [0.12-1.78],0.256220644124577,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PALM2,Paralemmin-2,Inverse variance weighted,9,1.22 [0.87-1.71],0.257138828552372,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.51 [0.16-1.64],0.260313201129503,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.89 [0.73-1.09],0.263103598987796,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.26 [0.84-1.9],0.264600661550123,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,0.86 [0.66-1.12],0.26509593472839,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.81 [0.64-5.14],0.266904482602649,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,3.27 [0.4-26.67],0.268331347314797,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,2.51 [0.49-12.86],0.270178434849143,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GOLM2,Protein GOLM2,Inverse variance weighted,14,0.86 [0.65-1.13],0.270393674004713,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.73 [0.42-1.27],0.27041428593295,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.84 [0.61-1.15],0.273500041916897,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.42 [0.76-2.65],0.276650022337022,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NCAN,Neurocan core protein,Inverse variance weighted,19,0.81 [0.56-1.18],0.277851906547561,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.65 [0.67-4.09],0.279829393053769,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,0.93 [0.81-1.06],0.280203828374686,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.85 [0.62-1.15],0.287198286521036,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,0.73 [0.4-1.31],0.288016374014223,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.18 [0.87-1.59],0.289896147398832,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,2,3.18 [0.37-27.2],0.290526683745488,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,0.73 [0.41-1.3],0.292532778043121,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.26 [0.82-1.93],0.29527070432447,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.38 [0.06-2.34],0.296676161210739,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.8 [0.53-1.22],0.299634723399458,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.83 [0.58-1.19],0.302412796213117,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.56 [0.67-3.62],0.302684431215849,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.15 [0.88-1.5],0.306756669188082,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.1 [0.92-1.31],0.307621546113078,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD99,CD99 antigen,Inverse variance weighted,4,1.44 [0.71-2.92],0.310573837950743,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LMNB1,Lamin-B1,Inverse variance weighted,3,1.46 [0.7-3.02],0.311194075996106,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.59 [0.21-1.64],0.311249815248116,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,20,0.83 [0.58-1.19],0.312112638472236,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.83 [0.57-5.91],0.314142791401901,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.77 [0.58-5.43],0.314615801650611,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.32 [0.77-2.27],0.315985538960023,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,1.61 [0.63-4.08],0.317400036979545,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GDF15,Growth/differentiation factor 15,Wald ratio,1,3.62 [0.29-45.57],0.319469379781585,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Inverse variance weighted,2,0.33 [0.04-2.91],0.31987996347729,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ELN,Elastin,Inverse variance weighted,10,0.73 [0.38-1.37],0.322297637159796,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC3B,Tetranectin,Inverse variance weighted,2,0.46 [0.1-2.16],0.32325655343024,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.57 [0.64-3.85],0.324582179967379,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.59 [0.21-1.68],0.325319370190869,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.74 [0.4-1.36],0.328279259158074,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRSS8,Prostasin,Inverse variance weighted,14,1.27 [0.78-2.06],0.331812128620543,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.7 [0.58-4.95],0.333745793771059,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NTF3,Neurotrophin-3,Inverse variance weighted,11,1.29 [0.77-2.18],0.334530861740174,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.34 [0.74-2.44],0.334842214257559,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,0.76 [0.44-1.33],0.338411693978439,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.63 [0.25-1.62],0.339256886590903,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.34 [0.73-2.44],0.340263885565837,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SRP14,Signal recognition particle 14 kDa protein,Inverse variance weighted,3,1.78 [0.54-5.88],0.341316617308446,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,3,1.42 [0.69-2.92],0.344509742158748,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.91 [0.74-1.11],0.344509804783651,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,4.87 [0.18-131.2],0.345896293943869,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.25 [0.78-1.99],0.346952802136641,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,0.88 [0.67-1.15],0.348725420909776,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.77 [0.44-1.33],0.348743021397986,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SERPINB8,Serpin B8,Inverse variance weighted,29,0.95 [0.85-1.06],0.352663950825263,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.84 [0.59-1.21],0.353587606304379,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.23 [0.79-1.9],0.356479715380274,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RSPO1,R-spondin-1,Inverse variance weighted,8,1.26 [0.77-2.05],0.356834568666795,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.5 [0.63-3.62],0.360802800678647,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.51 [0.12-2.2],0.368253277256716,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Inverse variance weighted,19,1.12 [0.87-1.44],0.370419759044999,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.63 [0.23-1.74],0.37206258519775,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.83 [0.54-1.26],0.372064891102747,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CFP,Properdin,Inverse variance weighted,17,0.86 [0.63-1.19],0.377334498708254,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AREG,Amphiregulin,Inverse variance weighted,5,0.57 [0.16-1.99],0.380596976624932,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,2.54 [0.31-20.79],0.383937931187057,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,7,1.21 [0.78-1.87],0.390582567002451,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LGALS9,Galectin-9,Inverse variance weighted,36,1.09 [0.89-1.33],0.392628764865004,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.59 [0.17-2],0.392999589979985,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.36 [0.67-2.72],0.393093333309935,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.71 [0.33-1.55],0.395036300121795,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",Inverse variance weighted,18,0.87 [0.62-1.21],0.399739795591241,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.28 [0.72-2.29],0.402016348966829,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,2.06 [0.38-11.22],0.403130533204726,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.93 [0.77-1.11],0.404222136409455,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,C9,Complement component C9,Inverse variance weighted,7,0.69 [0.29-1.66],0.405136139237338,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TCOF1,Treacle protein,Wald ratio,1,0.43 [0.06-3.19],0.405593877408577,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.71 [0.31-1.6],0.405891819266393,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.94 [0.81-1.09],0.406753142661464,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ITGB6,Integrin beta-6,Inverse variance weighted,16,0.86 [0.6-1.23],0.406815267807116,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.36 [0.66-2.82],0.408471739947806,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.92 [0.77-1.11],0.408597587452488,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL17C,Interleukin-17C,Inverse variance weighted,5,0.65 [0.23-1.82],0.409448276407902,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.41 [0.62-3.16],0.411101821094314,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,0.87 [0.64-1.2],0.411711873928181,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LMOD1,Leiomodin-1,Inverse variance weighted,6,1.18 [0.79-1.75],0.412045148624834,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PROC,Vitamin K-dependent protein C,Inverse variance weighted,40,1.05 [0.93-1.19],0.412708461995738,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SEPTIN8,Septin-8,Inverse variance weighted,4,1.39 [0.63-3.04],0.414108557021243,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.83 [0.53-1.3],0.416211383465171,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AMBP,Protein AMBP,Inverse variance weighted,5,0.81 [0.48-1.35],0.418673889566105,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.04 [0.94-1.16],0.418744549269038,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.19 [0.78-1.83],0.420698846399971,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RCC1,Regulator of chromosome condensation,Wald ratio,1,2.21 [0.32-15.21],0.42109497061519,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VCAN,Versican core protein,Inverse variance weighted,30,0.85 [0.58-1.25],0.421174708967809,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.63 [0.21-1.93],0.42126274611997,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.75 [0.38-1.5],0.421279815892744,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,C7,Complement component C7,Inverse variance weighted,26,1.07 [0.9-1.27],0.422084499084834,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,0.91 [0.72-1.15],0.423707072465616,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,0.8 [0.46-1.39],0.425983640893608,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,0.94 [0.8-1.1],0.426833166397848,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NECTIN4,Nectin-4,Inverse variance weighted,4,0.67 [0.25-1.8],0.430044765298401,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.91 [0.71-1.15],0.430358203664526,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.81 [0.48-1.37],0.435938108711497,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.95 [0.83-1.08],0.435964144137502,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,2,1.63 [0.48-5.56],0.436246051486825,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.07 [0.9-1.28],0.436969129664964,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.88 [0.64-1.21],0.440389018014936,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.81 [0.47-1.39],0.445894504751358,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.63 [0.19-2.07],0.4470617985881,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,1.33 [0.64-2.8],0.447800084195764,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.29 [0.66-2.51],0.451624441606354,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MPO,Myeloperoxidase,Inverse variance weighted,17,1.1 [0.86-1.39],0.453578177137183,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,1.19 [0.76-1.87],0.455183916555284,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTSO,Cathepsin O,Inverse variance weighted,19,1.1 [0.86-1.4],0.455705533602152,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,1.17 [0.78-1.76],0.459051040350704,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,0.96 [0.86-1.07],0.459205949565322,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.95 [0.84-1.08],0.46431169142603,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.34 [0.61-2.91],0.465274430412549,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.47 [0.06-3.58],0.468644039939485,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.32 [0.61-2.87],0.480347729789498,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.12 [0.82-1.53],0.481058725885786,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.94 [0.79-1.12],0.484982477517866,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Wald ratio,1,1.76 [0.36-8.71],0.486693851596605,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,F7,Coagulation factor VII,Inverse variance weighted,10,1.21 [0.71-2.05],0.487217350221961,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1.16 [0.77-1.74],0.488576715755572,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRSS2,Trypsin-2,Inverse variance weighted,17,0.88 [0.61-1.27],0.493259179384042,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.78 [0.39-1.58],0.495248402469307,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.8 [0.43-1.51],0.499539959898459,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.57 [0.42-5.87],0.499778240938961,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRTN3,Myeloblastin,Inverse variance weighted,20,1.12 [0.81-1.55],0.502135716120021,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.16 [0.75-1.79],0.503168769708715,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.61 [0.4-6.53],0.506564176001944,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD93,Complement component C1q receptor,Inverse variance weighted,2,1.45 [0.48-4.38],0.509577594132624,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,0.94 [0.79-1.13],0.509918214826088,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.1 [0.82-1.49],0.511400149708219,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,1.26 [0.63-2.53],0.512308156413977,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,F10,Coagulation factor X,Inverse variance weighted,11,1.13 [0.78-1.63],0.517711039279902,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EGFLAM,Pikachurin,Wald ratio,1,0.39 [0.02-6.73],0.518725563137287,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,REN,Renin,Inverse variance weighted,8,0.77 [0.36-1.69],0.519680909927976,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.53 [0.42-5.66],0.520423818615151,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.9 [0.64-1.25],0.52081960470174,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SERPINA11,Serpin A11,Inverse variance weighted,14,0.8 [0.4-1.59],0.523414329111717,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,0.81 [0.43-1.54],0.524389569534513,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1.12 [0.78-1.61],0.525742746403895,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PSIP1,PC4 and SFRS1-interacting protein,Wald ratio,1,1.98 [0.24-16.29],0.525937464595867,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCN5,CCN family member 5,Inverse variance weighted,12,1.12 [0.79-1.59],0.529412942863626,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.3 [0.58-2.92],0.530423884154979,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.55 [0.08-3.66],0.535498934523805,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CFD,Complement factor D,Wald ratio,1,1.77 [0.29-10.87],0.535549870123111,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.77 [0.33-1.79],0.53860841387201,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTSL,Cathepsin L1,Inverse variance weighted,29,1.1 [0.81-1.49],0.542440423525016,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,0.92 [0.72-1.19],0.543044392615619,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.39 [0.48-3.96],0.543751476211555,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,0.73 [0.26-2.04],0.544708486277222,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,0.88 [0.58-1.34],0.548035538933914,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,OSM,Oncostatin-M,Inverse variance weighted,6,1.28 [0.58-2.83],0.548452783834108,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,0.82 [0.43-1.57],0.548496127921585,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.06 [0.87-1.29],0.548710380426111,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,0.8 [0.39-1.64],0.548805006914263,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.28 [0.57-2.92],0.549321829124899,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,17,1.13 [0.75-1.69],0.552524531686416,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,33,1.05 [0.89-1.24],0.556769679021027,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD276,CD276 antigen,Inverse variance weighted,24,1.09 [0.82-1.44],0.559021876589181,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.85 [0.48-1.49],0.559934575913335,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,XCL1,Lymphotactin,Inverse variance weighted,15,1.19 [0.66-2.16],0.560056809000065,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.03 [0.92-1.16],0.560119652146818,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.81 [0.39-1.67],0.562676428753552,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RTBDN,Retbindin,Inverse variance weighted,2,1.98 [0.19-20.31],0.563554566173601,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.28 [0.55-2.96],0.565510112294452,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,1.12 [0.76-1.66],0.566064935878258,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.11 [0.78-1.56],0.566417369843321,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NRP1,Neuropilin-1,Inverse variance weighted,14,0.88 [0.56-1.37],0.567895850027319,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,0.87 [0.52-1.43],0.569592612691609,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.65 [0.15-2.85],0.570737800944297,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.91 [0.65-1.27],0.573764533782292,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ANG,Angiogenin,Inverse variance weighted,8,0.8 [0.36-1.76],0.576221165075909,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NRP2,Neuropilin-2,Inverse variance weighted,14,0.87 [0.54-1.41],0.578448338161759,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.77 [0.31-1.94],0.582500675292492,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,0.9 [0.61-1.32],0.583015604188827,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.22 [0.6-2.48],0.583027980477529,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.78 [0.32-1.91],0.583103330356799,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,XG,Glycoprotein Xg,Inverse variance weighted,2,2.04 [0.16-26.17],0.583599068523549,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,0.84 [0.44-1.59],0.585626772993809,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.96 [0.82-1.12],0.586999620014748,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Inverse variance weighted,16,0.85 [0.48-1.51],0.587021864161331,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PVR,Poliovirus receptor,Inverse variance weighted,3,1.49 [0.35-6.33],0.588837581947633,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.89 [0.6-1.34],0.589187303611161,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.1 [0.77-1.57],0.590936901038652,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNN,Tenascin-N,Inverse variance weighted,41,1.04 [0.9-1.2],0.592874353854388,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.76 [0.27-2.11],0.595313342921423,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.29 [0.5-3.36],0.596763880428335,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GSN,Gelsolin,Inverse variance weighted,7,1.18 [0.64-2.15],0.597866468625732,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.91 [0.65-1.29],0.600659628682108,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,0.97 [0.88-1.08],0.601787453808925,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HEPH,Hephaestin,Inverse variance weighted,6,0.9 [0.62-1.32],0.602061250083375,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.24 [0-51.85],0.603158600068455,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FBLN2,Fibulin-2,Inverse variance weighted,6,0.8 [0.34-1.86],0.60449502652849,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.82 [0.39-1.72],0.605424252984557,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.76 [0.27-2.17],0.607703345474193,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.08 [0.8-1.45],0.609804784527003,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL18,Interleukin-18,Inverse variance weighted,26,1.07 [0.82-1.39],0.610229353789741,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.16 [0.65-2.09],0.612497011606263,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.94 [0.72-1.21],0.613052814217112,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.13 [0.71-1.8],0.613841006482469,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GAST,Gastrin,Inverse variance weighted,9,1.13 [0.7-1.81],0.61462175842762,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,OGN,Mimecan,Inverse variance weighted,37,1.05 [0.87-1.27],0.616348210640907,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,0.88 [0.54-1.45],0.61655975956659,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,3,0.76 [0.25-2.27],0.618408421806486,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.95 [0.77-1.17],0.619540089138481,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,2,1.43 [0.35-5.79],0.620279416499774,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PKD2,Polycystin-2,Inverse variance weighted,3,0.75 [0.25-2.31],0.620803972514614,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.95 [0.78-1.16],0.621241383773734,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.83 [0.4-1.74],0.622748581529429,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1.18 [0.6-2.33],0.62404155540749,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.09 [0.76-1.57],0.625009334011512,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EPO,Erythropoietin,Inverse variance weighted,11,0.91 [0.64-1.31],0.625906780437364,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.19 [0.59-2.41],0.625930152987558,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.89 [0.55-1.44],0.627463049655727,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRTG,Protogenin,Inverse variance weighted,8,1.2 [0.57-2.53],0.627778382653195,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.16 [0.64-2.08],0.63002876006622,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.76 [0.24-2.37],0.630709682556712,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLK4,Kallikrein-4,Inverse variance weighted,5,0.73 [0.21-2.61],0.631613152610333,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TFF3,Trefoil factor 3,Inverse variance weighted,10,0.9 [0.58-1.4],0.639142666703481,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,1.22 [0.53-2.78],0.641670672545473,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.96 [0.79-1.16],0.642568842898083,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.49 [0.28-7.97],0.643561348667879,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ALCAM,CD166 antigen,Inverse variance weighted,4,1.14 [0.65-2.03],0.64367632186078,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,0.92 [0.65-1.3],0.643809678075739,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,0.94 [0.73-1.22],0.644243862506175,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.91 [0.59-1.38],0.645604689119721,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,26,1.06 [0.83-1.35],0.645833628428235,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,1.13 [0.68-1.86],0.646401861973326,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.28 [0.44-3.76],0.646796789765938,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.91 [0.61-1.36],0.646966805370121,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.87 [0.46-1.62],0.651373042546849,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.57 [0.22-11.25],0.65267213487886,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLSTN3,Calsyntenin-3,Inverse variance weighted,7,0.84 [0.4-1.78],0.655243129444331,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.62 [0.07-5.15],0.656172440936398,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,1.03 [0.9-1.18],0.657438882573208,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.89 [0.51-1.52],0.659055726515405,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,1.28 [0.42-3.88],0.661269789007357,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.11 [0.69-1.79],0.662081179561232,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,0.75 [0.21-2.73],0.664533304411279,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ITGA5,Integrin alpha-5,Inverse variance weighted,18,1.08 [0.76-1.55],0.666812363640658,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RSPO3,R-spondin-3,Inverse variance weighted,5,1.17 [0.56-2.46],0.668759068773812,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.03 [0.89-1.2],0.670154577889194,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,0.88 [0.48-1.6],0.670357724126059,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.96 [0.8-1.15],0.670401698493566,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MATN2,Matrilin-2,Inverse variance weighted,28,0.97 [0.83-1.13],0.671777922450514,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,0.94 [0.69-1.27],0.672009948775026,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.07 [0.78-1.48],0.67348081349591,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.2 [0.51-2.85],0.674567371623745,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.83 [0.36-1.95],0.675128034588411,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,0.86 [0.41-1.78],0.67608101416435,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.13 [0.64-2],0.677193487557869,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNC,Tenascin,Inverse variance weighted,57,0.97 [0.85-1.11],0.678904628584284,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.76 [0.21-2.8],0.679528783699788,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.03 [0.88-1.21],0.679723581092667,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.86 [0.42-1.77],0.687471526560446,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.72 [0.12-24.58],0.68818476657493,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,0.87 [0.45-1.69],0.688499311170364,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.05 [0.82-1.36],0.689199524303694,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.08 [0.74-1.56],0.691402709913198,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.07 [0.77-1.49],0.691992661907419,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CHGA,Chromogranin-A,Inverse variance weighted,5,1.13 [0.6-2.15],0.700213661811908,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.23 [0.43-3.56],0.70148956630089,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.1 [0.67-1.8],0.704033136384546,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.82 [0.29-2.33],0.705030356728645,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.94 [0.67-1.31],0.7072973659448,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.88 [0.44-1.74],0.707517027550872,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,1.05 [0.82-1.34],0.713544769382302,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.55 [0.02-13.88],0.717883849751873,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.93 [0.61-1.41],0.719021217475945,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PKD1,Polycystin-1,Inverse variance weighted,12,0.9 [0.5-1.61],0.722046676415633,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.89 [0.48-1.67],0.723103674613561,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CDH3,Cadherin-3,Inverse variance weighted,10,0.91 [0.55-1.51],0.727522507545145,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AGRN,Agrin,Inverse variance weighted,14,1.08 [0.7-1.66],0.736792408193956,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.04 [0.82-1.32],0.737279792861195,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.05 [0.78-1.41],0.737325902506378,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.1 [0.63-1.93],0.737535773010565,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PTH,Parathyroid hormone,Inverse variance weighted,11,1.08 [0.69-1.68],0.737798626080071,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,59,0.98 [0.86-1.11],0.739745586768023,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GRN,Progranulin,Inverse variance weighted,46,0.98 [0.84-1.13],0.742484679501455,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,1.27 [0.31-5.25],0.742729429095486,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.79 [0.19-3.34],0.748505904530023,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.88 [0.41-1.91],0.749654935219214,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NT5E,5'-nucleotidase,Inverse variance weighted,45,1.03 [0.86-1.23],0.749657579976806,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.19 [0.41-3.45],0.753372143180026,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,0.94 [0.65-1.37],0.754009283791099,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL24A1,Collagen alpha-1(XXIV) chain,Inverse variance weighted,3,0.77 [0.15-3.98],0.754149948227975,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CTSS,Cathepsin S,Inverse variance weighted,7,0.89 [0.44-1.82],0.754625550049102,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.45 [0.14-14.94],0.756574839698652,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,0.93 [0.6-1.46],0.757402454624727,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCN4,CCN family member 4,Inverse variance weighted,29,0.97 [0.8-1.17],0.758228402259234,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.07 [0.7-1.64],0.760336741976227,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.84 [0.27-2.6],0.761953302865677,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LCAT,Phosphatidylcholine-sterol acyltransferase,Inverse variance weighted,11,0.94 [0.64-1.39],0.766605833387379,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.07 [0.69-1.65],0.767449524269253,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VWC2,Brorin,Inverse variance weighted,12,1.09 [0.62-1.9],0.771412761456921,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,7,0.89 [0.4-1.98],0.771834226758657,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.8 [0.18-3.64],0.775994712029011,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MME,Neprilysin,Inverse variance weighted,46,0.97 [0.82-1.16],0.776539405511145,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BGLAP,Osteocalcin,Inverse variance weighted,8,0.9 [0.42-1.93],0.777675029621674,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,MMP10,Stromelysin-2,Wald ratio,1,1.36 [0.15-11.98],0.782666917092757,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.88 [0.34-2.25],0.783197238631137,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.91 [0.46-1.79],0.784629846958356,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,0.97 [0.75-1.24],0.784839920199285,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CAPG,Macrophage-capping protein,Wald ratio,1,1.25 [0.25-6.21],0.787786579419839,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,0.94 [0.61-1.45],0.792888659713344,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PTN,Pleiotrophin,Inverse variance weighted,3,1.26 [0.23-7],0.795055154969412,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,1.19 [0.32-4.51],0.796044617791102,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,0.96 [0.7-1.32],0.802882341738883,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLK11,Kallikrein-11,Inverse variance weighted,13,0.95 [0.62-1.46],0.807188516173072,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.92 [0.46-1.82],0.807281552587564,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.17 [0.33-4.07],0.808452471439773,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.06 [0.66-1.69],0.808963330481276,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.97 [0.74-1.26],0.810147496926194,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LGALS3,Galectin-3,Inverse variance weighted,15,1.06 [0.67-1.68],0.812088635286761,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.94 [0.56-1.58],0.81488805161191,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,38,0.98 [0.87-1.12],0.816366206797722,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.9 [0.36-2.26],0.818603742087011,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CST3,Cystatin-C,Inverse variance weighted,3,1.14 [0.36-3.67],0.820151150019125,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CDH6,Cadherin-6,Inverse variance weighted,5,0.89 [0.32-2.46],0.822157355585208,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.95 [0.59-1.53],0.822362716006512,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GUCA2A,Guanylin,Inverse variance weighted,7,1.07 [0.6-1.89],0.822787279739031,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,STC1,Stanniocalcin-1,Inverse variance weighted,9,0.96 [0.64-1.43],0.823291235425196,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.98 [0.78-1.21],0.82542832993931,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.05 [0.66-1.69],0.827247254675599,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DRAXIN,Draxin,Inverse variance weighted,25,1.04 [0.74-1.45],0.82749736614756,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.87 [0.26-2.94],0.828134300812539,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,0.98 [0.78-1.22],0.828295133026783,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,1.03 [0.8-1.32],0.828586103038343,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PALM,Paralemmin-1,Inverse variance weighted,4,0.91 [0.4-2.08],0.829319726208339,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,21,1.04 [0.72-1.52],0.829846552704286,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.92 [0.41-2.03],0.830053120176254,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,0.93 [0.49-1.77],0.830536412342051,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.89 [0.3-2.64],0.839261848311102,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.86-1.2],0.841218624653738,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.09 [0.45-2.67],0.844188993078189,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,0.93 [0.43-2],0.845168286367259,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.05 [0.63-1.74],0.845218915483351,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NECTIN2,Nectin-2,Inverse variance weighted,3,1.2 [0.19-7.68],0.845495464090811,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.98 [0.83-1.17],0.847509523491406,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.98 [0.81-1.19],0.852158153274723,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLC,Galectin-10,Inverse variance weighted,14,1.04 [0.69-1.57],0.852364771156446,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DSC2,Desmocollin-2,Inverse variance weighted,16,1.02 [0.79-1.32],0.853377684370852,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,15,0.96 [0.64-1.45],0.853827776480139,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.22 [0.14-10.72],0.854840732357221,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FOLR2,Folate receptor beta,Inverse variance weighted,14,1.06 [0.56-2.01],0.855481923166633,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.13 [0.3-4.19],0.85861853073368,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,APOA1,Apolipoprotein A-I,Inverse variance weighted,13,0.97 [0.66-1.41],0.863061979318484,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.08 [0.43-2.76],0.864903576755472,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL6,Interleukin-6,Inverse variance weighted,6,1.04 [0.68-1.58],0.867173812217186,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,0.96 [0.61-1.52],0.868553000459262,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL19,Interleukin-19,Inverse variance weighted,10,0.98 [0.76-1.26],0.870958368053555,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.23 [0.1-14.86],0.871208225955415,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,1.21 [0.12-11.76],0.87180248282586,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.01 [0.85-1.21],0.872587920185319,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.16 [0.19-6.86],0.872959751570337,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,1.12 [0.29-4.36],0.873074037617131,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,STC2,Stanniocalcin-2,Inverse variance weighted,10,0.95 [0.51-1.78],0.87406537298926,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,0.96 [0.57-1.61],0.879411712656909,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.1 [0.31-3.95],0.879420167422878,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.96 [0.58-1.6],0.883528817076046,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LGALS4,Galectin-4,Inverse variance weighted,15,1.02 [0.82-1.26],0.885448634615947,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ENG,Endoglin,Inverse variance weighted,18,0.99 [0.84-1.17],0.887020319979363,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.97 [0.68-1.39],0.887307267959835,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.96 [0.5-1.82],0.890709628414453,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SELPLG,P-selectin glycoprotein ligand 1,Inverse variance weighted,14,1.04 [0.58-1.87],0.891723765736256,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.06 [0.47-2.39],0.891931020042667,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,7,0.96 [0.5-1.83],0.894905372540965,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.98 [0.77-1.26],0.899796286201031,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.97 [0.61-1.54],0.900640818304851,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,4,1.07 [0.37-3.11],0.901861583292304,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.11 [0.21-6],0.902410097790299,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.96 [0.48-1.91],0.903213709696668,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SDC1,Syndecan-1,Inverse variance weighted,12,1.03 [0.67-1.58],0.90492128579149,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PGF,Placenta growth factor,Inverse variance weighted,5,1.04 [0.52-2.07],0.905969917886787,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLKB1,Plasma kallikrein,Inverse variance weighted,20,1.02 [0.73-1.42],0.90606739458805,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,0.95 [0.43-2.13],0.907859160860459,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,S100P,Protein S100-P,Inverse variance weighted,4,1.04 [0.53-2.03],0.908569982575797,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.01 [0.89-1.14],0.910273339345552,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,0.97 [0.55-1.72],0.916072533309909,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,UMOD,Uromodulin,Inverse variance weighted,34,1.02 [0.76-1.35],0.916077380254022,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,6,0.95 [0.35-2.6],0.918564113144292,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SPON1,Spondin-1,Inverse variance weighted,4,1.05 [0.37-3.02],0.923077008565926,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,KLK14,Kallikrein-14,Inverse variance weighted,15,0.98 [0.61-1.56],0.923199213885541,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,0.98 [0.71-1.37],0.923230239697547,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.05 [0.35-3.21],0.925840403822837,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PCDH17,Protocadherin-17,Inverse variance weighted,44,1.01 [0.88-1.16],0.927396046976975,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.95 [0.29-3.05],0.927732512408978,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,1.01 [0.87-1.17],0.929043922695253,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SCG2,Secretogranin-2,Inverse variance weighted,2,1.05 [0.36-3.1],0.929858850843266,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CNTN3,Contactin-3,Inverse variance weighted,20,1.02 [0.67-1.54],0.930585791158686,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.02 [0.7-1.47],0.931812353564991,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.03 [0.57-1.84],0.933951488650193,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.04 [0.4-2.69],0.939796989071043,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.03 [0.45-2.38],0.942332076780178,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.01 [0.8-1.27],0.944607855945502,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.99 [0.83-1.19],0.947115605611613,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CSTB,Cystatin-B,Inverse variance weighted,23,0.99 [0.84-1.18],0.947169793053829,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.03 [0.4-2.67],0.949073684314026,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,NFASC,Neurofascin,Inverse variance weighted,6,1.03 [0.43-2.47],0.949590477504848,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ROBO2,Roundabout homolog 2,Inverse variance weighted,6,1.02 [0.58-1.78],0.951895377618269,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.99 [0.78-1.26],0.953608727539858,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,1.01 [0.74-1.37],0.955996867246612,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,24,1.01 [0.8-1.26],0.956543401088882,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.01 [0.68-1.5],0.959915921596814,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1 [0.87-1.16],0.961747117098491,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,SLAMF8,SLAM family member 8,Inverse variance weighted,2,1.03 [0.3-3.54],0.962411661965778,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,BSG,Basigin,Inverse variance weighted,6,0.98 [0.47-2.08],0.964134706739735,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1 [0.86-1.16],0.967711287816625,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD27,CD27 antigen,Inverse variance weighted,9,0.99 [0.52-1.87],0.969701790499592,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,0.99 [0.71-1.39],0.973291109272234,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.98 [0.26-3.66],0.974199630240983,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.99 [0.48-2.05],0.975964285246684,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,1.01 [0.53-1.92],0.978074603307803,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.01 [0.38-2.69],0.978549875822946,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CALCA,Calcitonin,Inverse variance weighted,13,1.01 [0.59-1.71],0.978867967200926,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1 [0.7-1.43],0.978912315438378,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TTR,Transthyretin,Inverse variance weighted,11,1 [0.65-1.54],0.984308242817934,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1 [0.73-1.38],0.985384945451716,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1 [0.77-1.29],0.987290054358104,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.99 [0.41-2.42],0.987407628468093,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,LAYN,Layilin,Inverse variance weighted,3,0.99 [0.17-5.78],0.990606357272947,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,1 [0.86-1.16],0.991381121568528,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CXCL8,Interleukin-8,Inverse variance weighted,8,1 [0.49-2.04],0.991568678402279,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1 [0.23-4.3],0.995657509608426,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1 [0.82-1.22],0.99773407399535,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,CHGB,Secretogranin-1,Inverse variance weighted,7,1 [0.56-1.78],0.998300933278946,trans
Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1 [0.47-2.13],0.998303050109499,trans
